Genfit S.A. (EPA:GNFT)
France · Delayed Price · Currency is EUR 8.89
-0.38 (-4.10%)
Oct 22, 2026, 5:35 PM CEST
Genfit Market Cap
Genfit has a market cap or net worth of €444.78 million as of October 22, 2026. It is the 14,435th most valuable company in the world and the 194th biggest in France. Its market cap has increased by 141.02% in one year.
Market Cap
444.78M
Enterprise Value
510.23M
Revenue
59.49M
Global Rank
Country Rank
#194 France
PE Ratio
n/a
ChartMarket Cap Chart
Since December 20, 2006, Genfit's market cap has increased from 146.07M to 444.78M, an increase of 204.50%. That is a compound annual growth rate of 5.77%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 22, 2026 | 444.78M | 69.65% |
| Dec 31, 2025 | 262.17M | 48.73% |
| Dec 31, 2024 | 176.27M | 0.17% |
| Dec 29, 2023 | 175.98M | -10.69% |
| Dec 30, 2022 | 197.03M | -8.19% |
| Dec 31, 2021 | 214.62M | 38.52% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| MedinCell | 960.99M |
| Nanobiotix | 938.49M |
| Inventiva | 645.04M |
| DBV Technologies | 470.21M |
| Valneva SE | 452.50M |
| Valerio Therapeutics Société anonyme | 206.52M |
| Transgene | 187.06M |
| Innate Pharma | 118.25M |